<DOC>
	<DOCNO>NCT01734707</DOCNO>
	<brief_summary>This study design estimate effect two-year treatment time-released garlic-based drug Allicor progression carotid atherosclerosis double-blinded placebo-controlled randomized clinical trial .</brief_summary>
	<brief_title>Atherosclerosis Monitoring Atherogenicity Reduction Study</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>Men age 40 74 year Subclinical carotid atherosclerosis detect Bmode ultrasound ( increased intimamedia thickness 11002000 mcm ) Arterial normotension mild arterial hypertension ( systolic blood pressure &lt; 160 mm Hg , diastolic blood pressure &lt; 90 mm Hg ) Absence chronic disease demand permanent drug administration ( 2 month per year ) Personal history diagnostic following disease : 1 . Transient ischemic attack 2 . Presence chronic disease demand permanent drug administration ( 2 month per year ) 3 . Condition patient moderate severe Indications surgical treatment atherosclerotic lesion localize extracranial brachiocephalic system . Individual intolerance Allicor appearance side effect</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>regression</keyword>
	<keyword>Allicor</keyword>
	<keyword>garlic</keyword>
	<keyword>intima-media thickness</keyword>
</DOC>